By the reduction of streptomycin at its free carbonyl group, dihydrostreptomycin is prepared. The Activity of Stirepto;nycin and Dihydrostreptomycin Against Micro-organisms Streptomycin exerts an action against a large number of micro-organisms, both Gram positive and Gram negative. It is outstanding, however, in its effect upon Mycobacterium tuber-culosis. Investigations directed towards a comparison of streptomycin and its dihydro-derivative have shown that:
Firstly, under controlled conditions in vitro, the minimal concentrations at which the two drugs inhibit bacterial activity are virtually identical for a number of organisms. This certainly applies to M. tuberculosis (Donovick and Rake, 1947; Edison et al., 1948) .
Secondly, in vivo, both drugs are equally capable of prolonging the survival time of animals experimentally infected with M. tuberculosis, whether of human (H37Rv), bovine or avian strains (Rake et al., 1948; Edison et al., 1948; Feldman et al., 1948) .
Thirdly, in the treatment of human tuberculosis, the results with dihydrostreptomycin, at least by empirical assessment, are comparable with those obtained by the parent drug.
Finally, bacterial resistance to the two drugs may be regarded as parallel (Edison et al., 1948) .
Mode of Action
The precise mechanism by which streptomycin compounds bring about their anti-bacterial effect, though of considerable interest, is as yet beyond our understanding. Reviewing the bizarre data available from studies of bacterial metabolism, Florey et al. (1949) concluded that "in the case of sensitive strains, streptomycin interfered with some essential metabolite or metabolic process".
Absorption and Fate in the Body
Unlike penicillin, streptomycin given by mouth is not inactivated in the gut. Nevertheless it is poorly absorbed, if at all, from the alimentary tract, neither is it taken up from the lungs when exhibited as an aerosol (Florey et al., 1949) . Marshall (1948) , estimating streptomycin levels by a chemical as well as a calibrated antibacterial technique, concluded that:
After intravenous injection the maximum serum concentration is recorded within a few minutes. After intramuscular injection the maximum serum concentration is recorded within one or two hours.
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The maximum concentration attained after intramuscular injection is similar to that prevailing at the same interval of time after intravenous injection. In the dog, nearly all of the drug injected is excreted in the urine but in man this is not consistently so.
Distribution of the drug in a percentage of body weight approximates to its distribution in the extracellular fluid. Renal plasma clearances for streptomycin in both dog and man are less than the reported values for glomerular clearance so, unless there is any binding by plasma proteins, excretion is by glomerular filtration alone. After the introduction of streptomycin by the intramuscular route, appreciable quantities may be detected in most of the body fluids, including those of the eyes. There is also transportation across the placental barrier into the feetal circulation. By contrast, a negligible amount enters the red blood cells, thick-walled abscesses or large tuberculous cavities and comparatively little reaches the cerebrospinal fluid, except in the presence of acute meningitis. On the other hand, streptomycin may be given by the intrathecal route, when it is retained in the subarachnoid space for up to thirty hours (Florey et al., 1949) . Systemic dispersion from this site is then of a very low order.
Levin and his colleagues (Levin et al., 1948) , using for dihydrostreptomycin a modified cup-plate method of assay with Staph. ar-eus, found that its absorption, distribution and excretion followed the same pattern as streptomycin. They went on to deduce that any difference in behaviour of the two substances, therapeutically or toxicologically, must be attributed, not to variations in their concentrations in the body fluids but to other, probably intrinsic, factors. Toxicity Aclute.-ln themselves, figures for the lethal doses of streptomycin and dihydrostreptomycinare of little importance. However, as a basis of comparison between the two compounds, the following figures for the LD 50 in the case of mice are informative:
Streptomycin: 1,440 ± 116 mg./kg. body weight; Dihydrostreptomycin: 1,600 ± 108 mg./kg. body weight (Rake et al., 1948) . Local.-Experiments performed with animals, plants, protozoa (Florey et al., 1949) and tissue cultures (Keilover, 1948) disclosed that only in very high concentrations did streptomycin have any deleterious effect.
Chronic.-Since, in the management of tuberculosis, prolonged treatment is so often essential, studies on the chronic toxicity of the therapeutic agents employed are of particular significance.
In man, the toxic effects accruing after prolonged dosage with either of the streptomycin compounds are confined to: (i) Eosinophilia, sometimes associated with changes in the skin. (ii) Damage to the VIII nerve. Allelgic reactions. -Cohen and Glinsky (1951) formed the opinion that although streptomycin was not a primary skin irritant, hypersensitivity commonly developed, especially in those handling it.
According to Burn and Westlake (1949) the sensitization reactions to dihydrostreptomycin alone are much less common than those associated with the parent compound. What is more, the antigenic nature of the two substances is distinct. Consequently, in a patient already sensitized to streptomycin, the dihydro-derivative may be substituted without fear of continuing allergic manifestations.
Neurotoxicity.-With both streptomycin and dihydrostreptomycin this is confined to VIII nerve apparatus lesions.
In general, the degree of damage is related to the adopted dosage and to the blood levels obtained. The consensus of opinion now is that, provided a pure preparation is chosen and provided there is no incidence of renal damage which might occasion unduly high serum concentrations of the drug, 1 gramme streptomycin may be given daily for up to sixty days without any serious risk of neurotoxic consequences ( , Brit. med. J., i, 1043 .
What is particularly fascinating about this subject, at any rate academically, is the way in which streptomycin affects principally the vestibular apparatus, while the toxic impact of dihydrostreptomycin falls upon the auditory mechanism.
Professor F. C. Ormerod:
The original administration of 3 grammes a day of streptomycin produced deafness in a number of patients and vertigo in the majority. Reduction of the dose to 2 grammes daily abolished the deafness but vertigo occurred in two-thirds of the patients. Further reduction to 1 gramme lowered the incidence of vertigo to one-sixth of patients.
It was found that the vertigo began after 20 or 30 grammes had been administered. Some patients showed nystagmus but no vertigo and others vertigo but no nystagmus. In most cases, however, the two signs occurred together. It was noticed that in most cases there was reduction, if not loss, of response to caloric stimulation. Where the caloric responses were normal it could be safely assumed that the vertigo would disappear. When the responses were absent it was unusual, but not unknown, for recovery to take place. If the responses were reduced there was reasonable expectation that they would improve. Where the caloric responses disappear during the course of treatment, in the majority of cases they do not return. When tested at the end of the course of treatment these patients give a normal response to galvanic testing which suggests that the damage is in the sensory end-organ and not the nerve tracts. When tested a year later it was found that a few patients had lost their response to galvanic stimulation which suggested that secondary degeneration had taken place. When tested -again after three years there were no further degenerative changes, but a few had improved so that the caloric responses could be obtained, which suggests that the changes are reversible in some cases. Streptomycin only causes deafness when large doses of the drug have been given over long periods, such as 3 grammes daily for 120 days (Glorig). In such cases a degree of perceptive deafness occurs.
The vertigo seemed to be such a serious drawback to the use of streptomycin that work was done on variants of the original substance. Dihydrostreptomycin was evolved and it was claimed that this substance did not harm the inner ear and that its therapeutic effects were as good as those of streptomycin. It is true that vertigo hardly ever results from administration of dihydrostreptomycin but it has been found that perceptive deafness very often occurs. It may appear late in the course of treatment or even after the course is completed. The loss of hearing is severe and seems to be irreversible. The claim that it has better therapeutic effects than streptomycin does not seem to be borne out. The changes in the vestibular apparatus caused by streptomycin are ameliorated or disappear owing to compensatory adaptation and in many cases are not frequent or marked. The severe perceptive deafness caused by dihydrostreptomycin is a much more serious disability and there seems to be no excuse for the continued administration of this drug.
The site of the lesion: At first it was thought that the toxic lesion caused by streptomvcin was located in the nuclei of the two divisions of the VIII nerve in the hind-brain. This appeared to be confirmed by animal experiments in which degenerative changes were found in the hind-brain though the internal ears did not seem to have been examined in these cases. The amount of the drug used in these experiments was out of proportion to any possible therapeutic amount. In one series guinea-pigs were given amounts in three to four weeks that would have been equal to 600 grammes in man-about twenty times the normal dose. In some animals the general toxic effects were such that the animals died before any part of the VIII nerve system was involved. In some cases of this heavy dosage there were lesions in the central nuclei and in the end-organs and in others in the nuclei only.
Further. experiments have been carried out by Luzius Riledi, Raoul Causse, Aram Glorig and particularly by Karl Berg in which relatively therapeutic doses have been given to a series of animals. It has been shown that the majority of the changes take place in the organ of Corti, in the ampulle of the semicircular canals and the end organ of the saccule and utricle. In some animals there were changes in the bulbar nuclei but these were found only in animals which had been allowed to survive the administration of the drug for several months. These authors are all of the opinion as a result of these recent experiments that the primary effects of the drug involve the end-organs and destroy them. As a result of the destruction of the end organ degeneration in the neural portion of the system -takes place and shows itself in changes in the bulbar nuclei. We have been fortunate in obtaining through the kindness of Dr. W. L. Calnan a small series of temporal bones from cases who have died from tuberculous meningitis and who have had treatment with streptomycin or dihydrostreptomycin.
The temporal bones have been fixed and decalcified in the usual way and embedded in celloidin. Serial sections have been cut and consecutive ones including the internal ear and VIIt nerve have been stained and examined. The following cases are typical:
Proceedings of the Royal Society of Medictne 32 (l) D. H., boy aged 6 years. This child was treated for miliary tuberculosis for four months with intramuscular streptomycin 1 gramme daily. Treatment was discontinued for a month and he then developed tuberculous meningitis for which he was treated for six months with intramuscular and intrathecal streptomycin, followed by a further four months of intramuscular streptomycin which resulted in clinical recovery. He unfortunately died from acute appendicitis and peritonitis. At this time there was no evidence of tuberculosis and he was not deaf. The cochlea, vestibule and VIII nerve were normal.
(2) C. G., boy aged 6 years. This boy suffered from tuberculous meningitis and was treated for twenty-eight days by intramuscular injections of 2 grammes daily and by intrathecal injections of 50 mg. of streptomycin daily. The cochlea showed considerable lymphocytic infiltration which included the basilar membrane, organ of Corti, Reissner's membrane and the lateral wall of the scala media. There is a massive infiltration of the sheath of the nerve and at the junction of the cochlear and vestibular portions.
(3) H. M., girl aged 3, suffering from tuberculous meningitis. Intramuscular injection of streptomycin 1 gramme daily for four months and 2 grammes daily for final one and a half months. Also 50 mg. intrathecally for final one and a half months. In this case the cochlea was practically normal, but there was infiltration of the ganglion of the vestibular nerve by tuberculous granulation tissue and in the tissue of the nerve towards its cephalic end. (Fig. 1.) (4) J. W., girl aged 5, suffering from tuberculous meningitis. Treated by 50 mg. of dihydrostreptomycin daily intrathecally and 1 gramme intramuscularly for eight weeks. The cochlea and vestibule are normal but there is massive infiltration of the sheath of the VIII nerve with endothelioid cells, lymphocytes and giant cells. There is some lymphocytic infiltration of the nerve itself. (Fig. 2 Sunmnzary.-The striking feature about these sections is the extensive tuberculous infiltration in the sheath of the VIII nerve. This is similar in all of them in spite of the varying lengths of time of treatment, with the one exception who had recovered and died from appendicitis. Any slight changes in the cochlea are difficult to evaluate and it is not certain that they can be attributed to the toxic effect of the streptomycin. It may be that they are caused by a toxic irritation due to the tuberculous affection of the nerve in the immediate neighbourhood, or to some neurovascular change, again caused by the disease in the nerve. The lymph-cell infiltration of the structures of the cochlea confirms the suggestion of tuberculous toxxemia. It is realized that this is only a very small series but it was thought that the findings would be of interest. The suggestion has been made that deafness in some cases may be due to the meningitis and not to the antibiotic. The incidence of deafness in cerebrospinal and pneumococcal meningitis confirms this view and the rareness of deafness following streptomycin when given for other forms of tuberculosis supports it. The gross changes seen in the cochlear and vestibular nerves in these sections explain how deafness and vertigo can be produced.
Mr. A. S. Walker: Hearing of Patients after-Tuberculous Menlingitis.
Since September 1950 the Audiology Unit at Golden Square has had the oppoltuility of seeinig -some 93 patients who have recovered from tuberculous meningitis following streptomycin and dihydrostreptomycin treatment. Most of these patients (76) received streptomycin; a small number (6) 'had dihydrostreptomycin sulphate, and the remaining II cases started treatment with dihydrostreptomycin but later changed to streptomycin when the toxic effects of dihydrostreptomycin were made known.
A full history was obtained on each case from the various hospitals concerned. An examination w as made of the Ear, Nose and Throat. Tests of hearing and investigation of the vestibular reaction w ere carried out.
The following classification was used for assessing the degree of hearing loss.
(1) Total Deafness. Hearing nil. No response to loud sounds close to the ear even when amplified. No response to audiometry. (2) Subtotal deafness. Hearing for loud sounds only, e.g. drum or castanet.
A few "islets of hearing" may be found for pure tones, e.g. 128, 256, 512 at high intensity. Vowel discrimination may be absent or incomplete. (3) Partial deafness severe loss. A conversational voice cannot be heard at 3 ft.
Hearing is lost for consonants but is present for vowels. Audiograms show a severe loss, 70 decibels or more in the speech range. (4) Partial Deafness-moderate loss. A conversational voice can be heard at a distance of 3 ft. and up to 10 ft. Audiograms show a marked loss, in many cases up to 40 decibels. The test material consisted of word lists and sentences prepared by Fry and Reed. Caloric vestibular tests were carried out in the method described by Fitzgerald and Hallpike (1942) . Galvanic tests were carried out using the method described by Bignall, Crofton and Thomas (1951) . Dosage.-Although the patients seen came from various hospitals the dosage was more or less uniform. The intrathecal dose was 50 mg. daily for all except a few of the earliest cases who had 100 mg. daily. The intramuscular dosage was 20 mg. per lb. body weight daily in two doses twelve-,hourly in most cases, but some had 1 gramme daily in two doses twelve-hourly. PAS (sodium paraaminosalicylate) was given throughout in all cases. Dihydrostreptomycin was given in the same amounts as streptomycin.
At the outset the cases were unselected and consisted of all the cases treated at the Highgate Wing of the Archway Hospital Group. The incidence of deafness in this series of 30 cases was just under 37% and of these 17%Y were subtotally deaf. Following this practically all the patients were referred because of suspected deafness.
There was a most significant rise in the incidence of deafness amongst those 17 cases wxho had re-.ceived dihydrostreptomycin, or dihydrostreptomycin and streptomycin-more than 65(0 of these cases being severely deafened.
Calorics: In 10 patients who had normal hearing or suffered from a slight degree of deafness, 9 had a minimal response and 1 a diminished response. All the others tested had no response to cold caloric irrigation. The galvanic and Romberg's tests were positive in all cases. Some 15 cases have been re-tested within the last few weeks to observe if there had been any changes over a period of eighteen months, but the galvanic and caloric responses were unaltered from the original testing.
The onset of deafness was frequently heralded by a roaring tinnitus, and when this had subsided -.some degree of deafness was noted. In the great majority of cases this was slight at first, gradually increasing for two to three weeks, and then suddenly becoming much more severe in the fourth week (often then subtotal). Other cases had an insidious onset, the deafness gradually increasing over a period of three to four months. One adult treated throughout with dihydrostreptomycin sulphate became subtotally deaf in a period of seven days during the seventh month of treatment. In 8 patients no deafness was suspected on discharge from hospital, but became apparent some months after returning home-in 1 the deafness being slowly progressive over a period of six months.
The critical time for the onset of deafness was the fifth to sixth month, but in a few cases it was observed as early as the third month or as late as the fifteenth month after starting treatment.
Because of the possible onset of deafness from the fifth month one of the Units started giving a course of 100 consecutive daily injections intrathecally with no rest periods (this together with the usual intramuscular streptomycin and PAS). At the end of this period a very thorough clinical examination was made, and whenever possible a rest period of two to three weeks given. A further clinical examination was then made and if the patient's general condition permitted, the streptomycin was either stopped or re-started on alternate days. Some of the earlier cases, although suspected of being deaf, were not seen until the patients were in a stage of convalescence and ready to leave hospital. The result of this was that many who suffered from severe deafness had marked voice changes and in the younger age groups speech was lost.
The importance of patients being seen as soon as possible after the onset of deafness cannot be sufficiently stressed. Auditory training and lip-reading with the help of a hearing aid must be started at once.
As a result, many of the children in this series have returned to an ordinary school instead of a school for the deaf.
Mr. Terence Cawthorne: Streptomycin and its Use in Meinie'e's Disease
When it was found that streptomycin had a toxic effect upon the VIII nerve system, and in particular upon its vestibular division, the possibility of using this toxic effect therapeutically in cases of Meniere's disease was naturally considered. It had been shown that both sides of the vestibular system were equally sensitive to streptomycin, so this meant that if it were to be used in the treatment of Meniere's disease vestibular function on both sides would have to be sacrificed.
Hamberger and his colleagues found that the effects of bilateral vestibular failure following streptomycin therapy were easily overcome in children, fairly easily in young adults and seldom from middle age onwards. E. P. Fowler, Jr., pointed out that the effect of treating MWniere's disease with streptomycin was the same as a bilateral section of the vestibular nerve; and warned against its use in patients over 50 for the same reason as given by Hamberger. He also advised against usinig it for unilateral disease. Rijedi believes that the toxic effect is of the end-organ itself and not, as is held by many, upon the ganglion cells and nuclei. He considers that it may prove to be a valuable method of treating Meniere's disease and advises its use in small doses so that vestibular function is depressed without beinig entirely lost. My own feeling about this is that symptoms from a disordered labyrinth will continue so long as any vestibular function remains. Winston and others have pointed out that the toxic effect may not be confined to Vlll nerve centres in the central nervous system alone.
It has generally been found that 2 to 3 grammes daily for twenty days are sufficient to abolish vestibular function, but my experience has been that even with 3 grammes of streptomycin a day for thirty days vestibular function has not always been entirely abolished. In the last 4 patients to whom I gave streptomycin, vestibular function could not be abolished despite prolonged medication.
Little is, as yet, known about individual sensitivity to streptomycin. There is, however, some reason for believing that the vestibulo-toxic properties of streptomycin vary from brand to brand and possibly even from batch to batch. In my experience some of the earlier batches of streptomycin were much more toxic to the vestibular system than later ones, whilst it has, of course, been found that the dihydro compound which was chosen for its comparative lack of vestibulo-toxic properties has given much more trouble because of its effect on hearing.
Thus the problem is not quite so straightforward as it may at first sight appear, and streptomycin should not be used without considering the disadvantages that may accompany its use, and the fact that it may not work. A prolonged course of injections with streptomycin is not always well tolerated by patients, and one cannot even encourage them to persevere with the certainty that vestibular function will be entirely abolished. Even when this is achieved, the difficulty of compensating for bilateral loss of vestibular function may be great, particularly from middle age onwards. It must also be borne in mind that MWniere's disease affects the cochlear as well as the vestibular apparatus and, in bilateral cases, the cochlear symptoms may cause the greater distress and discomfort.
Streptomycin should not be used in the treatment of unilateral MWniere's disease. In bilateral cases it should only be considered in younger patients when all other measures have failed to control the attacks.
